プロバイオティクス栄養補助食品市場- 世界の市場規模、シェア、動向分析、機会、予測レポート、2019-2029年

プロバイオティクス栄養補助食品の世界市場規模が倍増以上、2029年までに395億米ドルに達する

世界のプロバイオティクス栄養補助食品市場は、胃腸疾患の有病率の上昇とビフィズス菌の用途の急増により、牽引力を増しています。

戦略コンサルティングと市場調査の大手企業であるBlueWeave Consultingは、最近の調査で、2022年のプロバイオティクス栄養補助食品の世界市場規模を178億5,000万米ドルと推定しました。2023年から2029年の予測期間中、プロバイオティクス栄養補助食品の世界市場規模は14.15％の驚異的なCAGRで成長し、2029年までに394億8,000万米ドルの値に達すると予測されています。プロバイオティクス栄養補助食品の世界市場は、胃潰瘍、感染症、アレルギーなどの腸関連疾患の発生率が上昇し、予防ヘルスケアや免疫力向上対策に関する消費者の知識が高まるにつれて発展すると予想されます。

本レポートの詳細な分析により、成長の可能性、今後の動向、世界のプロバイオティクス栄養補助食品市場に関する情報を提供します。また、総市場規模の予測を促進する要因にも焦点を当てています。本レポートは、世界のプロバイオティクス栄養補助食品市場における最近の技術動向と、意思決定者が健全な戦略的意思決定を行うための業界洞察を提供することを約束します。さらに、市場の成長促進要因・課題・競争力についても分析しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界のプロバイオティクス栄養補助食品市場の洞察

• 業界のバリューチェーン分析
• DROC分析
  • 成長促進要因
    • 急増するサッカロマイセス・ブラウディの用途
    • 胃腸疾患の有病率の上昇
    • 急増するビフィズス菌の用途
  • 抑制要因
    • プロバイオティクスの食事に伴う高額な費用
  • 機会
    • 健康意識の高まりによる需要の促進
    • 新興経済国における医療支出の大幅な増加
  • 課題
    • プロバイオティクス栄養補助食品の副作用
• 技術の進歩/最近の開発
• 規制の枠組み
• ポーターのファイブフォース分析

第4章 世界のプロバイオティクス栄養補助食品市場概要

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 形態別
    • チュアブル＆グミ
    • カプセル
    • 粉末
    • 錠剤とソフトジェル
    • その他
  • エンドユーザー別
    • 幼児
    • 子供
    • 成人
    • 高齢者向け
  • 用途別
    • 栄養補助食品
    • 栄養補助食品
    • 特殊栄養素
    • 乳児用調製粉乳
    • その他
  • 流通チャネル別
    • スーパーマーケットとハイパーマーケット
    • 薬局と健康店
    • オンラインストア
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋（APAC）
    • ラテンアメリカ（LATAM）
    • 中東およびアフリカ（MEA）

第5章 北米のプロバイオティクス栄養補助食品市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 形態別
  • エンドユーザー別
  • 用途別
  • 流通チャネル別
  • 国別
    • 米国
    • カナダ

第6章 欧州のプロバイオティクス栄養補助食品市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 形態別
  • エンドユーザー別
  • 用途別
  • 流通チャネル別
  • 国別
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • ベルギー
    • ロシア
    • オランダ
    • その他欧州

第7章 アジア太平洋のプロバイオティクス栄養補助食品市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 形態別
  • エンドユーザー別
  • 用途別
  • 流通チャネル別
  • 国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリアとニュージーランド
    • インドネシア
    • マレーシア
    • シンガポール
    • ベトナム
    • APACのその他の地域

第8章 ラテンアメリカのプロバイオティクス栄養補助食品市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 形態別
  • エンドユーザー別
  • 用途別
  • 流通チャネル別
  • 国別
    • ブラジル
    • メキシコ
    • アルゼンチン
    • ペルー
    • 中南米のその他の地域

第9章 中東およびアフリカのプロバイオティクス栄養補助食品市場

• 市場規模と予測、2019～2029年
  • 金額別
• 市場シェアと予測
  • 形態別
  • エンドユーザー別
  • 用途別
  • 流通チャネル別
  • 国別
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • クウェート
    • 南アフリカ
    • ナイジェリア
    • アルジェリア
    • MEAのその他の地域

第10章 競合情勢

• 主要企業とその製品のリスト
• 世界のプロバイオティクス栄養補助食品市場シェア分析、2022年
• 動作パラメータによる競合ベンチマーキング
• 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 COVID-19症がプロバイオティクス栄養補助食品市場に与える影響

第12章 企業プロファイル（会社概要、財務マトリックス、競合情勢、主要な人材、主要な競合、連絡先住所、戦略的展望、 SWOT分析）

• Vitakem Nutraceuticals Inc
• Lesaffre
• DuPont de Nemours, Inc.
• H&H Group
• Symrise
• ProbioFerm
• Dietary Pros, Inc.
• Chr. Hansen Holding A/S
• Dr. Joseph Mercola（Mercola Market）
• BASF SE
• ADM
• Amway
• Abbott
• Bayer AG
• Glanbia Plc
• Pfizer Inc.
• Other Prominent Players

第13章 主要な戦略的推奨事項

第14章 調査手法

• 定性的調査
  • 一次および2次調査
• 定量的調査
• 市場内訳とデータの三角測量
  • 2次調査
  • 1次調査
• 1次調査回答者の地域別内訳
• 前提と制限

Global Probiotic Dietary Supplements Market Size More Than Doubles to Touch USD 39.5 Billion by 2029

The global probiotic dietary supplements market is gaining traction because of the rising prevalence of gastrointestinal ailments and surging applications of bifidobacterium infantis.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global probiotic dietary supplements market size at USD 17.85 billion in 2022. During the forecast period between 2023 and 2029, the global probiotic dietary supplements market size is projected to grow at an impressive CAGR of 14.15% reaching a value of USD 39.48 billion by 2029. The global market for probiotic dietary supplements is expected to develop as the incidence of gut-related conditions such stomach ulcers, infections, and allergies rises and as consumer knowledge of preventive healthcare and immunity-boosting measures rises.

Global Probiotic Dietary Supplements Market - Overview:

Probiotics are a mix of living, healthy bacteria and/or yeast that exist naturally in the human body. Probiotics come in many different forms. They consist of certain yeasts (such as Saccharomyces boulardii), bifidobacteria (such as Bifidobacterium bifidus), and lactobacilli (such as Lactobacillus acidophilus and Lactobacillus GG). Probiotic dietary supplements are now widely utilized as food additives and supplements, mostly to support a healthy digestive system. Irritable bowel syndrome, some forms of diarrhea, colitis (especially ulcerative colitis and pouchitis, a consequence of surgery for ulcerative colitis), acne, and eczema in children may all benefit from the use of certain probiotics.

Global Probiotic Dietary Supplements Market - By Application:

Based on application, the global probiotic dietary supplements market is segmented into food supplements, nutritional supplements, specialty nutrients, infant formula, and others. The nutritional supplements segment holds the highest share of the global probiotic dietary supplements market. Probiotic supplements can aid in promoting the growth of beneficial bacteria while defending against bacteria that cause diseases. This collection of microbes is collectively referred to as the gut microbiota or gut microbiome, and it is essential to maintaining human health. In individuals aged 18 to 64, probiotic supplements may lower the risk of antibiotic-associated diarrhea.

Impact of COVID-19 on the Global Probiotic Dietary Supplements Market

The global probiotic dietary supplements market saw tremendous growth prospects due to the unprecedented COVID-19 pandemic. During the pandemic, demand for immunity-boosting drugs increased as people began spending more on their health. The surge in popularity of online retailers also significantly increased the market penetration of probiotic dietary supplements. During the lockdown, many online pharmacies and supermarket retailers provided discounts and contactless door delivery of their goods, considerably boosting the market growth.

Competitive Landscape:

Major players operating in the global probiotic dietary supplements market include: Vitakem Nutraceuticals Inc, Lesaffre, DuPont de Nemours, Inc., H&H Groupm Symrise, ProbioFerm, Dietary Pros, Inc., Chr. Hansen Holding A/S, Dr. Joseph Mercola (Mercola Market), BASF SE, ADM, Amway, Abbott, Bayer AG, Glanbia Plc, and Pfizer Inc.

To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Probiotic Dietary Supplements Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Probiotic Dietary Supplements Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Probiotic Dietary Supplements Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Soaring applications of saccharomyces boulardii
    • 3.2.1.2. Rising prevalence of gastrointestinal ailments
    • 3.2.1.3. Surging applications of bifidobacterium infantis
  • 3.2.2. Restraints
    • 3.2.2.1. High costs associated with probiotic dietary
  • 3.2.3. Opportunities
    • 3.2.3.1. Increasing health awareness promoting demand
    • 3.2.3.2. Significant increase in health expenditure in emerging economies
  • 3.2.4. Challenges
    • 3.2.4.1. Side effects of probiotic dietary supplements
• 3.3. Technology Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Probiotic Dietary Supplements Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Billion)
• 4.2. Market Share and Forecast
  • 4.2.1. By Form
    • 4.2.1.1. Chewable & Gummies
    • 4.2.1.2. Capsules
    • 4.2.1.3. Powders
    • 4.2.1.4. Tablets & Soft gels
    • 4.2.1.5. Others
  • 4.2.2. By End User
    • 4.2.2.1. Infants
    • 4.2.2.2. Children
    • 4.2.2.3. Adults
    • 4.2.2.4. Geriatric
  • 4.2.3. By Application
    • 4.2.3.1. Food Supplement
    • 4.2.3.2. Nutritional Supplements
    • 4.2.3.3. Specialty Nutrients
    • 4.2.3.4. Infant Formula
    • 4.2.3.5. Others
  • 4.2.4. By Distribution Channel
    • 4.2.4.1. Supermarkets & Hypermarkets
    • 4.2.4.2. Pharmacy & Health Stores
    • 4.2.4.3. Online Stores
    • 4.2.4.4. Others
  • 4.2.5. By Region
    • 4.2.5.1. North America
    • 4.2.5.2. Europe
    • 4.2.5.3. Asia Pacific (APAC)
    • 4.2.5.4. Latin America (LATAM)
    • 4.2.5.5. Middle East and Africa (MEA)

5. North America Probiotic Dietary Supplements Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Billion)
• 5.2. Market Share & Forecast
  • 5.2.1. By Form
  • 5.2.2. By End User
  • 5.2.3. By Application
  • 5.2.4. By Distribution Channel
  • 5.2.5. By Country
    • 5.2.5.1. United States
    • 5.2.5.1.1. By Form
    • 5.2.5.1.2. By End User
    • 5.2.5.1.3. By Application
    • 5.2.5.1.4. By Distribution Channel
    • 5.2.5.2. Canada
    • 5.2.5.2.1. By Form
    • 5.2.5.2.2. By End User
    • 5.2.5.2.3. By Application
    • 5.2.5.2.4. By Distribution Channel

6. Europe Probiotic Dietary Supplements Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Billion)
• 6.2. Market Share & Forecast
  • 6.2.1. By Form
  • 6.2.2. By End User
  • 6.2.3. By Application
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
    • 6.2.5.1. Germany
    • 6.2.5.1.1. By Form
    • 6.2.5.1.2. By End User
    • 6.2.5.1.3. By Application
    • 6.2.5.1.4. By Distribution Channel
    • 6.2.5.2. United Kingdom
    • 6.2.5.2.1. By Form
    • 6.2.5.2.2. By End User
    • 6.2.5.2.3. By Application
    • 6.2.5.2.4. By Distribution Channel
    • 6.2.5.3. Italy
    • 6.2.5.3.1. By Form
    • 6.2.5.3.2. By End User
    • 6.2.5.3.3. By Application
    • 6.2.5.3.4. By Distribution Channel
    • 6.2.5.4. France
    • 6.2.5.4.1. By Form
    • 6.2.5.4.2. By End User
    • 6.2.5.4.3. By Application
    • 6.2.5.4.4. By Distribution Channel
    • 6.2.5.5. Spain
    • 6.2.5.5.1. By Form
    • 6.2.5.5.2. By End User
    • 6.2.5.5.3. By Application
    • 6.2.5.5.4. By Distribution Channel
    • 6.2.5.6. Belgium
    • 6.2.5.6.1. By Form
    • 6.2.5.6.2. By End User
    • 6.2.5.6.3. By Application
    • 6.2.5.6.4. By Distribution Channel
    • 6.2.5.7. Russia
    • 6.2.5.7.1. By Form
    • 6.2.5.7.2. By End User
    • 6.2.5.7.3. By Application
    • 6.2.5.7.4. By Distribution Channel
    • 6.2.5.8. The Netherlands
    • 6.2.5.8.1. By Form
    • 6.2.5.8.2. By End User
    • 6.2.5.8.3. By Application
    • 6.2.5.8.4. By Distribution Channel
    • 6.2.5.9. Rest of Europe
    • 6.2.5.9.1. By Form
    • 6.2.5.9.2. By End User
    • 6.2.5.9.3. By Application
    • 6.2.5.9.4. By Distribution Channel

7. Asia-Pacific Probiotic Dietary Supplements Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Billion)
• 7.2. Market Share & Forecast
  • 7.2.1. By Form
  • 7.2.2. By End User
  • 7.2.3. By Application
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
    • 7.2.5.1. China
    • 7.2.5.1.1. By Form
    • 7.2.5.1.2. By End User
    • 7.2.5.1.3. By Application
    • 7.2.5.1.4. By Distribution Channel
    • 7.2.5.2. India
    • 7.2.5.2.1. By Form
    • 7.2.5.2.2. By End User
    • 7.2.5.2.3. By Application
    • 7.2.5.2.4. By Distribution Channel
    • 7.2.5.3. Japan
    • 7.2.5.3.1. By Form
    • 7.2.5.3.2. By End User
    • 7.2.5.3.3. By Application
    • 7.2.5.3.4. By Distribution Channel
    • 7.2.5.4. South Korea
    • 7.2.5.4.1. By Form
    • 7.2.5.4.2. By End User
    • 7.2.5.4.3. By Application
    • 7.2.5.4.4. By Distribution Channel
    • 7.2.5.5. Australia & New Zealand
    • 7.2.5.5.1. By Form
    • 7.2.5.5.2. By End User
    • 7.2.5.5.3. By Application
    • 7.2.5.5.4. By Distribution Channel
    • 7.2.5.6. Indonesia
    • 7.2.5.6.1. By Form
    • 7.2.5.6.2. By End User
    • 7.2.5.6.3. By Application
    • 7.2.5.6.4. By Distribution Channel
    • 7.2.5.7. Malaysia
    • 7.2.5.7.1. By Form
    • 7.2.5.7.2. By End User
    • 7.2.5.7.3. By Application
    • 7.2.5.7.4. By Distribution Channel
    • 7.2.5.8. Singapore
    • 7.2.5.8.1. By Form
    • 7.2.5.8.2. By End User
    • 7.2.5.8.3. By Application
    • 7.2.5.8.4. By Distribution Channel
    • 7.2.5.9. Vietnam
    • 7.2.5.9.1. By Form
    • 7.2.5.9.2. By End User
    • 7.2.5.9.3. By Application
    • 7.2.5.9.4. By Distribution Channel
    • 7.2.5.10. Rest of APAC
    • 7.2.5.10.1. By Form
    • 7.2.5.10.2. By End User
    • 7.2.5.10.3. By Application
    • 7.2.5.10.4. By Distribution Channel

8. Latin America Probiotic Dietary Supplements Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Billion)
• 8.2. Market Share & Forecast
  • 8.2.1. By Form
  • 8.2.2. By End User
  • 8.2.3. By Application
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
    • 8.2.5.1. Brazil
    • 8.2.5.1.1. By Form
    • 8.2.5.1.2. By End User
    • 8.2.5.1.3. By Application
    • 8.2.5.1.4. By Distribution Channel
    • 8.2.5.2. Mexico
    • 8.2.5.2.1. By Form
    • 8.2.5.2.2. By End User
    • 8.2.5.2.3. By Application
    • 8.2.5.2.4. By Distribution Channel
    • 8.2.5.3. Argentina
    • 8.2.5.3.1. By Form
    • 8.2.5.3.2. By End User
    • 8.2.5.3.3. By Application
    • 8.2.5.3.4. By Distribution Channel
    • 8.2.5.4. Peru
    • 8.2.5.4.1. By Form
    • 8.2.5.4.2. By End User
    • 8.2.5.4.3. By Application
    • 8.2.5.4.4. By Distribution Channel
    • 8.2.5.5. Rest of LATAM
    • 8.2.5.5.1. By Form
    • 8.2.5.5.2. By End User
    • 8.2.5.5.3. By Application
    • 8.2.5.5.4. By Distribution Channel

9. Middle East & Africa Probiotic Dietary Supplements Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Billion)
• 9.2. Market Share & Forecast
  • 9.2.1. By Form
  • 9.2.2. By End User
  • 9.2.3. By Application
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
    • 9.2.5.1. Saudi Arabia
    • 9.2.5.1.1. By Form
    • 9.2.5.1.2. By End User
    • 9.2.5.1.3. By Application
    • 9.2.5.1.4. By Distribution Channel
    • 9.2.5.2. UAE
    • 9.2.5.2.1. By Form
    • 9.2.5.2.2. By End User
    • 9.2.5.2.3. By Application
    • 9.2.5.2.4. By Distribution Channel
    • 9.2.5.3. Qatar
    • 9.2.5.3.1. By Form
    • 9.2.5.3.2. By End User
    • 9.2.5.3.3. By Application
    • 9.2.5.3.4. By Distribution Channel
    • 9.2.5.4. Kuwait
    • 9.2.5.4.1. By Form
    • 9.2.5.4.2. By End User
    • 9.2.5.4.3. By Application
    • 9.2.5.4.4. By Distribution Channel
    • 9.2.5.5. South Africa
    • 9.2.5.5.1. By Form
    • 9.2.5.5.2. By End User
    • 9.2.5.5.3. By Application
    • 9.2.5.5.4. By Distribution Channel
    • 9.2.5.6. Nigeria
    • 9.2.5.6.1. By Form
    • 9.2.5.6.2. By End User
    • 9.2.5.6.3. By Application
    • 9.2.5.6.4. By Distribution Channel
    • 9.2.5.7. Algeria
    • 9.2.5.7.1. By Form
    • 9.2.5.7.2. By End User
    • 9.2.5.7.3. By Application
    • 9.2.5.7.4. By Distribution Channel
    • 9.2.5.8. Rest of MEA
    • 9.2.5.8.1. By Form
    • 9.2.5.8.2. By End User
    • 9.2.5.8.3. By Application
    • 9.2.5.8.4. By Distribution Channel

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Probiotic Dietary Supplements Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Probiotic Dietary Supplements Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. Vitakem Nutraceuticals Inc
• 12.2. Lesaffre
• 12.3. DuPont de Nemours, Inc.
• 12.4. H&H Group
• 12.5. Symrise
• 12.6. ProbioFerm
• 12.7. Dietary Pros, Inc.
• 12.8. Chr. Hansen Holding A/S
• 12.9. Dr. Joseph Mercola (Mercola Market)
• 12.10. BASF SE
• 12.11. ADM
• 12.12. Amway
• 12.13. Abbott
• 12.14. Bayer AG
• 12.15. Glanbia Plc
• 12.16. Pfizer Inc.
• 12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations